Matthew D. Shin

1.2k total citations · 1 hit paper
18 papers, 809 citations indexed

About

Matthew D. Shin is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Matthew D. Shin has authored 18 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Matthew D. Shin's work include SARS-CoV-2 and COVID-19 Research (6 papers), Bacteriophages and microbial interactions (4 papers) and Plant Virus Research Studies (4 papers). Matthew D. Shin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Bacteriophages and microbial interactions (4 papers) and Plant Virus Research Studies (4 papers). Matthew D. Shin collaborates with scholars based in United States, United Kingdom and Portugal. Matthew D. Shin's co-authors include Nicole F. Steinmetz, Oscar A. Ortega‐Rivera, Jonathan K. Pokorski, Veronique Beiss, Sourabh Shukla, David M. Wirth, Young Hun Chung, M. Sack, Soo Khim Chan and W. Y. Ching and has published in prestigious journals such as Journal of the American Chemical Society, Nature Nanotechnology and Biomaterials.

In The Last Decade

Matthew D. Shin

18 papers receiving 788 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19 vaccine development and a potential nanomaterial path forward

2020 492 citations Matthew D. Shin, Sourabh Shukla et al. Nature Nanotechnology profile →

Peers

Countries citing papers authored by Matthew D. Shin

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Shin more than expected).

Fields of papers citing papers by Matthew D. Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Shin. The network helps show where Matthew D. Shin may publish in the future.

Co-authorship network of co-authors of Matthew D. Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Shin. A scholar is included among the top collaborators of Matthew D. Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Shin. Matthew D. Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Pluronic F127 “nanoarmor” for stabilization of Cowpea mosaic virus immunotherapy 2023 ·Bioengineering & Translational Medicine ·Matthew D. Shin, Eunkyeong Jung, (unknown), Oscar A. Ortega‐Rivera, Nicole F. Steinmetz	8
2	COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response 2023 ·Frontiers in Microbiology ·Jessica Fernanda Affonso de Oliveira, Zhongchao Zhao, Yi Xiang, Matthew D. Shin, (unknown), Xinyi Deng, Sourabh Shukla, Shaochen Chen, Nicole F. Steinmetz	6
3	A Single‐Dose Qβ VLP Vaccine against S100A9 Protein Reduces Atherosclerosis in a Preclinical Model 2022 ·Advanced Therapeutics ·Oscar A. Ortega‐Rivera, Matthew D. Shin, (unknown), Jonathan K. Pokorski, Nicole F. Steinmetz	8
4	Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate 2022 ·Biomacromolecules ·Christian Isalomboto Nkanga, Oscar A. Ortega‐Rivera, Matthew D. Shin, (unknown), Nicole F. Steinmetz	35
5	Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol Efflux 2022 ·Bioconjugate Chemistry ·Matthew D. Shin, Oscar A. Ortega‐Rivera, Nicole F. Steinmetz	4
6	A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells 2021 ·Drug Delivery and Translational Research ·(unknown), (unknown), Matthew D. Shin, Cynthia Berlinicke, Hyounkoo Han, Nicole M. Anders, (unknown), (unknown), (unknown), (unknown), (unknown), Usha Rai, (unknown), Charles G. Eberhart, Ian Pitha, Donald J. Zack, Justin Hanes, Laura M. Ensign	13
7	Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein Thrombosis 2021 ·Biomacromolecules ·(unknown), Amy M. Wen, Huiyun Gao, Matthew D. Shin, Daniel I. Simon, Yunmei Wang, Nicole F. Steinmetz	11
8	Bioconjugation of Active Ingredients to Plant Viral Nanoparticles Is Enhanced by Preincubation with a Pluronic F127 Polymer Scaffold 2021 ·ACS Applied Materials & Interfaces ·Matthew D. Shin, (unknown), Jonathan K. Pokorski, Nicole F. Steinmetz	12
9	Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination 2021 ·Expert Opinion on Drug Delivery ·Miguel Pereira‐Silva, Gaurav Chauhan, Matthew D. Shin, Clare Hoskins, Marc Madou, Sergio O. Martínez‐Chapa, Nicole F. Steinmetz, Francisco Veiga, Ana Cláudia Paiva‐Santos	23
10	Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus 2021 ·ACS Infectious Diseases ·Oscar A. Ortega‐Rivera, Sourabh Shukla, Matthew D. Shin, Angela Chen, Veronique Beiss, (unknown), Yi Zheng, Alex E. Clark, Aaron F. Carlin, Jonathan K. Pokorski, Nicole F. Steinmetz	20
11	Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices 2021 ·Journal of the American Chemical Society ·Oscar A. Ortega‐Rivera, Matthew D. Shin, Angela Chen, Veronique Beiss, (unknown), Miguel Alejandro Lopez‐Ramirez, Maria Reynoso, Hong Wang, Brett L. Hurst, Joseph Wang, Jonathan K. Pokorski, Nicole F. Steinmetz	54
12	COVID-19 vaccine development and a potential nanomaterial path forward breakdown → 2020 ·Nature Nanotechnology ·Matthew D. Shin, Sourabh Shukla, Young Hun Chung, Veronique Beiss, Soo Khim Chan, Oscar A. Ortega‐Rivera, David M. Wirth, (unknown), M. Sack, Jonathan K. Pokorski, Nicole F. Steinmetz	492
13	Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization 2020 ·Biomaterials ·Sean F. Hackett, Jie Fu, (unknown), Hiroki Tsujinaka, Jikui Shen, Raquel Lima e Silva, Mahmood Khan, (unknown), Tao Wang, Matthew D. Shin, Nicole M. Anders, Ping He, Laura M. Ensign, Justin Hanes, Peter A. Campochiaro	37
14	Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding 2020 ·Physical Chemistry Chemical Physics ·Puja Adhikari, Neng Li, Matthew D. Shin, Nicole F. Steinmetz, Reidun Twarock, Rudolf Podgornik, W. Y. Ching	51
15	Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD+-dependent deacetylases 2014 ·Oncogene ·Fan Yeung, (unknown), (unknown), David F. Allison, (unknown), Matthew D. Shin, Manish Kumar, (unknown), James A. McCubrey, Marty W. Mayo	12
16	Antisense-Mediated Inhibition of Arginase (CAR1) Gene Expression in Saccharomyces cerevisiae. 2001 ·Journal of Bioscience and Bioengineering ·Hye‐Jin Park, Matthew D. Shin, In Sook Woo	18
17	Transport of 1,3-bis(1,2-chloroethyl)-1-nitrosourea (BCNU) in the brain transport of following controlled release by a polymer 1995 ·Lawrence K. Fung, Matthew D. Shin, Jessica M. Strasser, (unknown), Eric P. Sipos, Betty Tyler, Henry Brem, W. Mark Saltzman	1
18	Membrane factors responsible for homologous species restriction of complement mediated lysis 1985 ·Matthew D. Shin, Gertrud Maria Hänsch, Andreas Weller	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact